C4 Therapeutics (CCCC) Shares Outstanding (2019 - 2025)
Historic Shares Outstanding for C4 Therapeutics (CCCC) over the last 7 years, with Q3 2025 value amounting to $74.2 million.
- C4 Therapeutics' Shares Outstanding rose 511.83% to $74.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $74.2 million, marking a year-over-year increase of 511.83%. This contributed to the annual value of $70.6 million for FY2024, which is 1680.04% up from last year.
- Per C4 Therapeutics' latest filing, its Shares Outstanding stood at $74.2 million for Q3 2025, which was up 511.83% from $71.0 million recorded in Q2 2025.
- Over the past 5 years, C4 Therapeutics' Shares Outstanding peaked at $74.2 million during Q3 2025, and registered a low of $43.1 million during Q1 2021.
- Moreover, its 5-year median value for Shares Outstanding was $49.1 million (2023), whereas its average is $57.2 million.
- Per our database at Business Quant, C4 Therapeutics' Shares Outstanding soared by 314625.18% in 2021 and then surged by 38.35% in 2023.
- Over the past 5 years, C4 Therapeutics' Shares Outstanding (Quarter) stood at $48.7 million in 2021, then increased by 0.57% to $49.0 million in 2022, then increased by 23.49% to $60.5 million in 2023, then grew by 16.8% to $70.6 million in 2024, then increased by 5.02% to $74.2 million in 2025.
- Its Shares Outstanding was $74.2 million in Q3 2025, compared to $71.0 million in Q2 2025 and $71.0 million in Q1 2025.